Cargando…
Lack of Synergy Between β-Agonist Treatment and a Blockage of Sarcoplasmic Calcium Flow in a Rat Cancer Cachexia Model
BACKGROUND: During cancer cachexia, both skeletal muscle and adipose tissue losses take place. The use of β2-agonists, formoterol in particular, has proven to be very successful in the treatment of the syndrome in pre-clinical models. The object of the present research was to study the effects of a...
Autores principales: | Busquets, Silvia, Castillejo, Marta, Jové, Queralt, Jude, Baptiste, Mejías, Patricia, López-Soriano, Francisco J, Argilés, Josep M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982712/ https://www.ncbi.nlm.nih.gov/pubmed/33762827 http://dx.doi.org/10.2147/OTT.S293834 |
Ejemplares similares
-
Effects of S‐pindolol in mouse pancreatic and lung cancer cachexia models
por: Springer, Jochen, et al.
Publicado: (2023) -
Nonmuscle Tissues Contribution to Cancer Cachexia
por: Argilés, Josep M., et al.
Publicado: (2015) -
Therapeutic strategies against cancer cachexia
por: Argilés, Josep M., et al.
Publicado: (2019) -
Optimal management of cancer anorexia–cachexia syndrome
por: Argilés, Josep M, et al.
Publicado: (2010) -
Are there any benefits of exercise training in cancer cachexia?
por: Argilés, Josep M., et al.
Publicado: (2012)